NeuroOne Medical TechnologiesNMTC
About: NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
Employees: 17
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
3,050% more call options, than puts
Call options by funds: $63K | Put options by funds: $2K
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
23% more capital invested
Capital invested by funds: $1.34M [Q4 2024] → $1.64M (+$304K) [Q1 2025]
1.0% more ownership
Funds ownership: 5.25% [Q4 2024] → 6.25% (+1.0%) [Q1 2025]
10% less funds holding
Funds holding: 20 [Q4 2024] → 18 (-2) [Q1 2025]
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Ladenburg Thalmann Jeff Cohen | 153%upside $1.45 | Buy Initiated | 5 May 2025 |
Financial journalist opinion









